{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:55:13Z","timestamp":1790726113127,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Liaoning Province","award":["Grant No. 2024-MSLH-585"],"award-info":[{"award-number":["Grant No. 2024-MSLH-585"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04729-z","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:16:20Z","timestamp":1783138580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Self-assembling pH-responsive peptide nanoparticles delivering pyrvinium pamoate induce osteosarcoma senescence through CBX4 ubiquitination\u2013mediated inhibition of YAP1 SUMOylation"],"prefix":"10.1186","volume":"24","author":[{"given":"Renyi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"key":"4729_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2741\/4373","volume":"21","author":"X Shi","year":"2016","unstructured":"Shi X. The progress of molecular diagnostics of osteosarcoma. Front Biosci. 2016;21:20\u201330. https:\/\/doi.org\/10.2741\/4373.","journal-title":"Front Biosci"},{"key":"4729_CR2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nrendo.2017.16","volume":"13","author":"DM Gianferante","year":"2017","unstructured":"Gianferante DM, Mirabello L, Savage SA. Germline and somatic genetics of osteosarcoma \u2014 connecting aetiology, biology and therapy. Nat Reviews Endocrinol. 2017;13:480\u201391. https:\/\/doi.org\/10.1038\/nrendo.2017.16.","journal-title":"Nat Reviews Endocrinol"},{"key":"4729_CR3","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.3390\/ijms23073817","volume":"23","author":"MA Harris","year":"2022","unstructured":"Harris MA, Hawkins CJ. Recent and Ongoing Research into Metastatic Osteosarcoma Treatments. Int J Mol Sci. 2022;23:3817. https:\/\/doi.org\/10.3390\/ijms23073817.","journal-title":"Int J Mol Sci"},{"key":"4729_CR4","doi-asserted-by":"publisher","first-page":"6885","DOI":"10.3390\/ijms21186885","volume":"21","author":"I Lilienthal","year":"2020","unstructured":"Lilienthal I, Herold N. Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies. Int J Mol Sci. 2020;21:6885. https:\/\/doi.org\/10.3390\/ijms21186885.","journal-title":"Int J Mol Sci"},{"key":"4729_CR5","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.3390\/cancers14153611","volume":"14","author":"F Barghi","year":"2022","unstructured":"Barghi F, Shannon HE, Saadatzadeh MR, Bailey BJ, Riyahi N, Bijangi-Vishehsaraei K, et al. Precision Medicine Highlights Dysregulation of the CDK4\/6 Cell Cycle Regulatory Pathway in Pediatric, Adolescents and Young Adult Sarcomas. Cancers. 2022;14:3611. https:\/\/doi.org\/10.3390\/cancers14153611.","journal-title":"Cancers"},{"key":"4729_CR6","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.3390\/cancers14143503","volume":"14","author":"B Moukengue","year":"2022","unstructured":"Moukengue B, Lallier M, Marchandet L, Baud\u2019huin M, Verrecchia F, Ory B, et al. Origin and Therapies of Osteosarcoma. Cancers. 2022;14:3503. https:\/\/doi.org\/10.3390\/cancers14143503.","journal-title":"Cancers"},{"key":"4729_CR7","doi-asserted-by":"publisher","unstructured":"Otoukesh B, Boddouhi B, Moghtadaei M, Kaghazian P, Kaghazian M. Novel molecular insights and new therapeutic strategies in osteosarcoma. Cancer Cell Int. 2018;18. https:\/\/doi.org\/10.1186\/s12935-018-0654-4.","DOI":"10.1186\/s12935-018-0654-4"},{"key":"4729_CR8","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.3390\/cells11213507","volume":"11","author":"Z Hu","year":"2022","unstructured":"Hu Z, Wen S, Huo Z, Wang Q, Zhao J, Wang Z, et al. Current Status and Prospects of Targeted Therapy for Osteosarcoma. Cells. 2022;11:3507. https:\/\/doi.org\/10.3390\/cells11213507.","journal-title":"Cells"},{"key":"4729_CR9","doi-asserted-by":"publisher","first-page":"105684","DOI":"10.1016\/j.phrs.2021.105684","volume":"169","author":"Y Chen","year":"2021","unstructured":"Chen Y, Liu R, Wang W, Wang C, Zhang N, Shao X, et al. Advances in targeted therapy for osteosarcoma based on molecular classification. Pharmacol Res. 2021;169:105684. https:\/\/doi.org\/10.1016\/j.phrs.2021.105684.","journal-title":"Pharmacol Res"},{"key":"4729_CR10","doi-asserted-by":"publisher","unstructured":"Wang S, Ren Q, Li G, Zhao X, Zhao X, Zhang Z. The Targeted Therapies for Osteosarcoma via Six Major Pathways. Curr Mol Pharmacol. 2023;17. https:\/\/doi.org\/10.2174\/1874467217666230821142839.","DOI":"10.2174\/1874467217666230821142839"},{"key":"4729_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1089\/ars.2020.8043","volume":"34","author":"R Shmulevich","year":"2021","unstructured":"Shmulevich R, Krizhanovsky V. Cell Senescence, DNA Damage, and Metabolism. Antioxid Redox Signal. 2021;34:324\u201334. https:\/\/doi.org\/10.1089\/ars.2020.8043.","journal-title":"Antioxid Redox Signal"},{"key":"4729_CR12","doi-asserted-by":"publisher","unstructured":"Kumari R, Jat P. Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype. Front Cell Dev Biology. 2021;9. https:\/\/doi.org\/10.3389\/fcell.2021.645593.","DOI":"10.3389\/fcell.2021.645593"},{"key":"4729_CR13","doi-asserted-by":"publisher","first-page":"101136","DOI":"10.1016\/j.drup.2024.101136","volume":"77","author":"Y Gu","year":"2024","unstructured":"Gu Y, Xu T, Fang Y, Shao J, Hu T, Wu X, et al. CBX4 counteracts cellular senescence to desensitize gastric cancer cells to chemotherapy by inducing YAP1 SUMOylation. Drug Resist Updates. 2024;77:101136. https:\/\/doi.org\/10.1016\/j.drup.2024.101136.","journal-title":"Drug Resist Updates"},{"key":"4729_CR14","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3390\/cells9040972","volume":"9","author":"H Kovar","year":"2020","unstructured":"Kovar H, Bierbaumer L, Radic-Sarikas B. The YAP\/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis. Cells. 2020;9:972. https:\/\/doi.org\/10.3390\/cells9040972.","journal-title":"Cells"},{"key":"4729_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2147\/bctt.s381856","volume":"14","author":"H Tian","year":"2022","unstructured":"Tian H, Zhao T, Li Y, Sun N, Ma D, Shi Q, et al. Chromobox Family Proteins as Putative Biomarkers for Breast Cancer Management: A Preliminary Study Based on Bioinformatics Analysis and qRT-PCR Validation. Breast Cancer: Targets Therapy. 2022;14:515\u201335. https:\/\/doi.org\/10.2147\/bctt.s381856.","journal-title":"Breast Cancer: Targets Therapy"},{"key":"4729_CR16","doi-asserted-by":"publisher","first-page":"115659","DOI":"10.1016\/j.bone.2020.115659","volume":"143","author":"AJ van Wijnen","year":"2021","unstructured":"van Wijnen AJ, Bagheri L, Badreldin AA, Larson AN, Dudakovic A, Thaler R, et al. Biological functions of chromobox (CBX) proteins in stem cell self-renewal, lineage-commitment, cancer and development. Bone. 2021;143:115659. https:\/\/doi.org\/10.1016\/j.bone.2020.115659.","journal-title":"Bone"},{"key":"4729_CR17","doi-asserted-by":"publisher","unstructured":"Gomarasca M, Lombardi G, Maroni P. SUMOylation and NEDDylation in Primary and Metastatic Cancers to Bone. Front Cell Dev Biology. 2022;10. https:\/\/doi.org\/10.3389\/fcell.2022.889002.","DOI":"10.3389\/fcell.2022.889002"},{"key":"4729_CR18","doi-asserted-by":"publisher","unstructured":"Wang X, Qin G, Liang X, Wang W, Wang Z, Liao D, et al. Targeting the CK1\u03b1\/CBX4 axis for metastasis in osteosarcoma. Nat Commun. 2020;11. https:\/\/doi.org\/10.1038\/s41467-020-14870-4.","DOI":"10.1038\/s41467-020-14870-4"},{"key":"4729_CR19","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1042\/bcj20200506","volume":"477","author":"LJ Fulcher","year":"2020","unstructured":"Fulcher LJ, Sapkota GP. Functions and regulation of the serine\/threonine protein kinase CK1 family: moving beyond promiscuity. Biochem J. 2020;477:4603\u201321. https:\/\/doi.org\/10.1042\/bcj20200506.","journal-title":"Biochem J"},{"key":"4729_CR20","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.3390\/ijms21113904","volume":"21","author":"H-B Park","year":"2020","unstructured":"Park H-B, Kim J-W, Baek K-H. Regulation of Wnt Signaling through Ubiquitination and Deubiquitination in Cancers. Int J Mol Sci. 2020;21:3904. https:\/\/doi.org\/10.3390\/ijms21113904.","journal-title":"Int J Mol Sci"},{"key":"4729_CR21","doi-asserted-by":"publisher","unstructured":"Deng L, Meng T, Chen L, Wei W, Wang P. The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Therapy. 2020;5. https:\/\/doi.org\/10.1038\/s41392-020-0107-0.","DOI":"10.1038\/s41392-020-0107-0"},{"key":"4729_CR22","doi-asserted-by":"publisher","unstructured":"Basu B, Ghosh MK. Ubiquitination and deubiquitination in the regulation of epithelial-mesenchymal transition in cancer: Shifting gears at the molecular level. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2022;1869:119261. https:\/\/doi.org\/10.1016\/j.bbamcr.2022.119261","DOI":"10.1016\/j.bbamcr.2022.119261"},{"key":"4729_CR23","doi-asserted-by":"publisher","first-page":"880","DOI":"10.20892\/j.issn.2095-3941.2024.0231","volume":"21","author":"J Shen","year":"2024","unstructured":"Shen J, Lai Y, Wu Y, Lin X, Zhang C, Liu H. Ubiquitination in osteosarcoma: unveiling the impact on cell biology and therapeutic strategies. Cancer Biology Med. 2024;21:880\u201397. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2024.0231.","journal-title":"Cancer Biology Med"},{"key":"4729_CR24","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.3390\/biomedicines10123249","volume":"10","author":"CW Schultz","year":"2022","unstructured":"Schultz CW, Nevler A, Pyrvinium Pamoate. Past, Present, and Future as an Anti-Cancer Drug. Biomedicines. 2022;10:3249. https:\/\/doi.org\/10.3390\/biomedicines10123249.","journal-title":"Biomedicines"},{"key":"4729_CR25","doi-asserted-by":"publisher","unstructured":"Wu K, Yu B, Li D, Tian Y, Liu Y, Jiang J. Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma. Front Oncol. 2022;12. https:\/\/doi.org\/10.3389\/fonc.2022.805978.","DOI":"10.3389\/fonc.2022.805978"},{"key":"4729_CR26","doi-asserted-by":"publisher","first-page":"101607","DOI":"10.1016\/j.mtbio.2025.101607","volume":"32","author":"K Cui","year":"2025","unstructured":"Cui K, Ren F, Yu J, Pan H. Bioinspired nanomedicines for the management of osteosarcoma: Recent progress and perspectives. Mater Today Bio. 2025;32:101607. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101607.","journal-title":"Mater Today Bio"},{"key":"4729_CR27","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1080\/1061186x.2024.2349124","volume":"32","author":"H Sun","year":"2024","unstructured":"Sun H, Li X, Liu Q, Sheng H, Zhu L. pH-responsive self-assembled nanoparticles for tumor-targeted drug delivery. J Drug Target. 2024;32:672\u2013706. https:\/\/doi.org\/10.1080\/1061186x.2024.2349124.","journal-title":"J Drug Target"},{"key":"4729_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-00999-x","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang X, Wan K, Zhou N, Wei G, Su Z. Supramolecular peptide nano-assemblies for cancer diagnosis and therapy: from molecular design to material synthesis and function-specific applications. J Nanobiotechnol. 2021. https:\/\/doi.org\/10.1186\/s12951-021-00999-x. 19.","journal-title":"J Nanobiotechnol"},{"key":"4729_CR29","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1007\/s11033-021-06963-0","volume":"49","author":"S Ergin","year":"2022","unstructured":"Ergin S, Kherad N, Alagoz M. RNA sequencing and its applications in cancer and rare diseases. Mol Biol Rep. 2022;49:2325\u201333. https:\/\/doi.org\/10.1007\/s11033-021-06963-0.","journal-title":"Mol Biol Rep"},{"key":"4729_CR30","doi-asserted-by":"publisher","unstructured":"Lang J, Cho WC, Huang T, Wu T, Xu J, Editorial. Applications of RNA-seq in cancer and tumor research. Front Genet. 2023;14. https:\/\/doi.org\/10.3389\/fgene.2023.1331576.","DOI":"10.3389\/fgene.2023.1331576"},{"key":"4729_CR31","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1038\/s41596-018-0075-9","volume":"13","author":"J Elegheert","year":"2018","unstructured":"Elegheert J, Behiels E, Bishop B, Scott S, Woolley RE, Griffiths SC, et al. Lentiviral transduction of mammalian cells for fast, scalable and high-level production of soluble and membrane proteins. Nat Protoc. 2018;13:2991\u20133017. https:\/\/doi.org\/10.1038\/s41596-018-0075-9.","journal-title":"Nat Protoc"},{"key":"4729_CR32","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/s41418-022-00964-7","volume":"29","author":"E Lieschke","year":"2022","unstructured":"Lieschke E, Wang Z, Chang C, Weeden CE, Kelly GL, Strasser A. Flow cytometric single cell-based assay to simultaneously detect cell death, cell cycling, DNA content and cell senescence. Cell Death Differ. 2022;29:1004\u201312. https:\/\/doi.org\/10.1038\/s41418-022-00964-7.","journal-title":"Cell Death Differ"},{"key":"4729_CR33","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1042\/bj20061873","volume":"405","author":"B Li","year":"2007","unstructured":"Li B, Zhou J, Liu P, Hu J, Jin H, Shimono Y, et al. Polycomb protein Cbx4 promotes SUMO modification of de novo DNA methyltransferase Dnmt3a. Biochem J. 2007;405:369\u201378. https:\/\/doi.org\/10.1042\/bj20061873.","journal-title":"Biochem J"},{"key":"4729_CR34","doi-asserted-by":"publisher","unstructured":"Liu Y, Jiang Z, Tong S, Sun Y, Zhang Y, Zhang J, et al. Acidity-Triggered Transformable Polypeptide Self\u2010Assembly to Initiate Tumor\u2010Specific Biomineralization. Adv Mater. 2023;2203291. https:\/\/doi.org\/10.1002\/adma.202203291.","DOI":"10.1002\/adma.202203291"},{"key":"4729_CR35","doi-asserted-by":"publisher","first-page":"113642","DOI":"10.1016\/j.jconrel.2025.113642","volume":"382","author":"G Sun","year":"2025","unstructured":"Sun G, Wu Y, Li J, Yang M, Xu H, Li Y, et al. Quercetin liposomes conjugated with hyaluronidase: An efficient drug delivery system to block pancreatic cancer. J Controlled Release. 2025;382:113642. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113642.","journal-title":"J Controlled Release"},{"key":"4729_CR36","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1158\/0008-5472.can-14-3216","volume":"75","author":"GL Nicolson","year":"2015","unstructured":"Nicolson GL. Cell Membrane Fluid\u2013Mosaic Structure and Cancer Metastasis. Cancer Res. 2015;75:1169\u201376. https:\/\/doi.org\/10.1158\/0008-5472.can-14-3216.","journal-title":"Cancer Res"},{"key":"4729_CR37","doi-asserted-by":"publisher","unstructured":"Wu F, Li D. YB1 and its role in osteosarcoma: a review. Front Oncol. 2024;14. https:\/\/doi.org\/10.3389\/fonc.2024.1452661.","DOI":"10.3389\/fonc.2024.1452661"},{"key":"4729_CR38","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.3390\/ph18121774","volume":"18","author":"L Ruiz-Virgen","year":"2025","unstructured":"Ruiz-Virgen L, Salazar-Garc\u00eda JL, Gardu\u00f1o-Wilches IA, Rojas-L\u00f3pez M, Mart\u00ednez-Mej\u00eda G, Caro-Briones R, et al. Polymeric Nanoparticles with Surface-Anchored Functional Groups as Chelating Agents for Calcium (Ca2+) and Magnesium (Mg2+) Ions to Inhibit Cellular Interactions. Pharmaceuticals. 2025;18:1774. https:\/\/doi.org\/10.3390\/ph18121774.","journal-title":"Pharmaceuticals"},{"key":"4729_CR39","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1021\/acs.accounts.8b00195","volume":"51","author":"J-Z Du","year":"2018","unstructured":"Du J-Z, Li H-J, Wang J. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine. Acc Chem Res. 2018;51:2848\u201356. https:\/\/doi.org\/10.1021\/acs.accounts.8b00195.","journal-title":"Acc Chem Res"},{"key":"4729_CR40","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/cells13060537","volume":"13","author":"J Di Gregorio","year":"2024","unstructured":"Di Gregorio J, Di Giuseppe L, Terreri S, Rossi M, Battafarano G, Pagliarosi O, et al. Protein Stability Regulation in Osteosarcoma: The Ubiquitin-like Modifications and Glycosylation as Mediators of Tumor Growth and as Targets for Therapy. Cells. 2024;13:537. https:\/\/doi.org\/10.3390\/cells13060537.","journal-title":"Cells"},{"key":"4729_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8835714","volume":"2020","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, Ma Y, Li Z, Zhang K, Zheng M, Zhang S. The Function of SUMOylation and Its Role in the Development of Cancer Cells under Stress Conditions: A Systematic Review. Stem Cells Int. 2020;2020:1\u201316. https:\/\/doi.org\/10.1155\/2020\/8835714.","journal-title":"Stem Cells Int"},{"key":"4729_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00473-z","author":"S Piccolo","year":"2022","unstructured":"Piccolo S, Panciera T, Contessotto P, Cordenonsi M. YAP\/TAZ as master regulators in cancer: modulation, function and therapeutic approaches. Nat Cancer. 2022. https:\/\/doi.org\/10.1038\/s43018-022-00473-z.","journal-title":"Nat Cancer"},{"key":"4729_CR43","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/life15010126","volume":"15","author":"PS Bruno","year":"2025","unstructured":"Bruno PS, Arshad A, Gogu M-R, Waterman N, Flack R, Dunn K, et al. Post-Translational Modifications of Proteins Orchestrate All Hallmarks of Cancer. Life. 2025;15:126. https:\/\/doi.org\/10.3390\/life15010126.","journal-title":"Life"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04729-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04729-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04729-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:57:22Z","timestamp":1790722642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04729-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4729"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04729-z","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Animal Ethics Committee of The First Hospital of China Medical University (Approval No. CMUKT2025182).Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"911"}}